Pain in lower limb
|
phenotype |
|
Sign or Symptom
|
31
|
2
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2020 |
Muscle damage
|
phenotype |
|
Acquired Abnormality
|
163
|
4
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.010 |
None |
1.000 |
1 |
|
1985 |
1985 |
psychological distress
|
disease |
|
Mental or Behavioral Dysfunction
|
87
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
[D]Sleep disturbances (& [hypersomnia] or [insomnia])
|
phenotype |
|
Sign or Symptom
|
69
|
23
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
PEROXISOME BIOGENESIS DISORDER, COMPLEMENTATION GROUP A
|
disease |
|
Disease or Syndrome
|
34
|
3
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
response to bronchodilator
|
phenotype |
|
Organism Function
|
131
|
1106
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
741
|
81
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.090 |
None |
1.000 |
9 |
|
2017 |
2020 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.090 |
None |
1.000 |
9 |
|
2017 |
2020 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2020 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.040 |
None |
1.000 |
4 |
|
2018 |
2020 |
Aortic Valve Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
377
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Vasculitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
294
|
24
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Biventricular congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Transposition of Great Vessels
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
61
|
18
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Freeman-Sheldon syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
26
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Xanthinuria, Type II
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
8
|
0.720 |
None |
1.000 |
4 |
4
|
2001 |
2018 |